LACTULOSE-MIP 650mg / ml syrup medication leaflet

A06AD11 lactulose • Alimentary tract and metabolism | Drugs for constipation | Osmotically acting laxatives

Lactulose is an osmotic laxative used to treat chronic constipation and hepatic encephalopathy. It works by drawing water into the intestines, softening stools and promoting bowel movement. Additionally, it alters gut flora, promoting beneficial bacteria and reducing blood ammonia levels, which is helpful in liver conditions.

It is administered orally or rectally and has a gradual effect, usually becoming effective within 24-48 hours. Lactulose is preferred over other laxatives due to its safety profile and is commonly used in children, pregnant women, and the elderly.

It is primarily used for chronic constipation but also serves as an adjunct therapy in hepatic encephalopathy to prevent toxin buildup in the body. Compared to other laxatives, it has a gentler effect and a lower risk of dependency.

Side effects may include bloating, flatulence, abdominal cramps, and diarrhea, especially at high doses. It is not recommended for individuals with severe lactose intolerance or intestinal obstruction.

General data about LACTULOSE-MIP 650mg / ml

Substance: lactulose

Date of last drug list: 01-01-2019

Commercial code: W54245004

Concentration: 650mg / ml

Pharmaceutical form: syrup

Packing volume: 1000ml

Product type: generic

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: CHEPHASAAR CHEM.-PHARM. FABRIK GMBH - GERMANIA

Holder: MIP PHARMA GMBH - GERMANIA

Number: 6675/2014/04

Shelf life: 3 years; sub 25°C after first opening the bottle

Pharmaceutical forms available for lactulose

Concentrations available for lactulose

10g/15ml, 12g, 650mg/ml, 66.7%, 660mg/ml, 667mg/ml, 67%, 670mg/ml, 6g

Other substances similar to lactulose